Cormedix Inc.
A biopharmaceutical company that makes Defencath, a catheter lock solution used by kidney-dialysis patients to prevent bloodstream infections and blood clotting. Founded in 2006 by Antony P. Pfaffle, the firm began life as Picton Holding Company and was renamed CorMedix a few months later. The name blends the Latin "cor" (heart) with "medix," a nod to the medical conditions it addresses.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| SHAIBATALHAMD AYMEN ABDALKADER | 13G/APassive | 5.9% | 4.62M | Jun 12, 2026 |
| Deep Track Capital, LP | 13G/APassive | 7.94% | 6.27M | May 15, 2026 |
| Deep Track Biotechnology Master Fund, Ltd. | 13G/APassive | 7.94% | 6.27M | May 15, 2026 |
| David Kroin | 13G/APassive | 7.94% | 6.27M | May 15, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| BlackRock, Inc. | 13G/APassive | 7.5% | 4.57M | Feb 5, 2025 |